Zhitong Finance App News, Sinopharm Hyundai (600420.SH) issued an announcement. Recently, Sinopharm Group Industry Co., Ltd. (Sinopharm Industry for short), a wholly-owned subsidiary of the company, received the “Drug Registration Certificate” for clonazepam injections approved and issued by the State Drug Administration. Clonazepam injection is a second-class psychotropic drug. It is mainly used to control various types of seizures, especially for syncope attacks, infantile cramps, myoclonic, ataxic seizures, and Lennox-Gastaut syndrome.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.